Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Musculoskeletal stiffness, Pain
Clinical narrative: A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.; A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.; A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.; This spontaneous case was reported by a patient and describes the occurrence of MUSCULOSKELETAL STIFFNESS (A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.), ASTHENIA (A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.) and PAIN (A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.) in an elderly male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. 8058628) for COVID-19 vaccination.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:None, he is healthy.  Previously administered products included for Drug use for unknown indication: Pfizer (Dose 1 (Lot number was unknown)) in December 2020, Pfizer (2nd dose: 2-3 months after was not sure of the recommended interval between the 1st 2 vaccines.) in March 2021, Pfizer (Dose 3 (Lot number was unknown)) in September 2021 and Pfizer (Dose 4 (Lot number was unknown)) in October 2022. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer, Pfizer and Pfizer.    On 13-Nov-2023, the patient received fifth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.), ASTHENIA (A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.) and PAIN (A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.). At the time of the report, MUSCULOSKELETAL STIFFNESS (A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.), ASTHENIA (A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.) and PAIN (A physician states that he got the Spikevax two and a half weeks ago and he has had persistent muscle stiffness, weakness and achiness.) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.  The patient wanted to know when these side effects would resolve and if he can do something about these and specified that the muscles that are involved are the deltoids, hamstrings and the gluteals (buttocks). It hampered what he did, and just wanted reassurance. He did not have his vaccination card with him during the call.